UNC-0631 | m-entrepreneurship.com

Product Name :
UNC-0631

Search keywords :
UNC 0631

drugId :
null

Target Vo:
Histone-lysine N-methyltransferase EHMT2

Target Vo Short Name :
EHMT2

Moa_Name:
Histone-lysine N-methyltransferase EHMT2 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
University Of North Carolina At Chapel Hill

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
RNA Polymerase II Subunit B1 Antibody
MMP9 Antibody
CIDEC Antibody (YA911): CIDEC Antibody (YA911) is an unconjugated, approximately 27 kDa, mouse-derived, anti-CIDEC (YA911) monoclonal antibody. CIDEC Antibody (YA911) can be used for: WB, ICC/IF, FC expriments in human background without labeling.

Author: Betaine hydrochloride

Related Posts